Personalized Medicine

Can a personalized medicine approach to pancreatic cancer treatment make a difference? Learn about new studies focusing on precision medicine.

22 Articles

Dr. Jashodeep Datta
Research
May 23, 2024 • 4 Min

Study Reveals Molecular Differences in Young-Onset Pancreatic Cancer

There has been a notable increase in cases of young onset pancreatic cancer. Dr. Jashodeep Datta and team are exploring why this is happening.

pipette in the lab
Research
December 30, 2022 • 5 Min

A Year in Review: 2022 in Research

What progress was made in pancreatic treatment and screening? Learn about the major pancreatic cancer developments of 2022.

Dr. Joshua Rabinowitz
Research
June 22, 2022 • 4 Min

Laboratory Study Shows Keto Diet May Enhance Chemotherapy

Dr. Joshua Rabinowitz’s initial study has found that a Keto diet may enhance the effects of chemotherapy and treatment for pancreatic cancer.

Lola Rahib and Patrick van der Valk
Research
March 8, 2022 • 4 Min

Cancer Commons and xCures Hope to Use Real-World Data to Improve Care

Lola Rahib and Patrick van der Valk explain how Cancer Commons and xCures are using real-world data to improve care for future patients.

Gehan Botrus
Research
July 26, 2021 • 5 Min

Finding More Clues about Circulating Tumor DNA

Researcher Dr. Gehan Botrus looks at circulating tumor DNA for genetic information on a patient’s pancreatic cancer to personalize treatment.

Kenneth Yu, MD
Research
February 22, 2021 • 5 Min

Blood-Based Test Predicts What Drugs May Work Best

Dr. Kenneth Yu is testing a blood-based assay that looks at which types of chemotherapies will work best for each pancreatic cancer patient.

Dr. Andrea Califano
Research
February 9, 2021 • 4 Min

RNA Precision Trial for Pancreatic Cancer Opens At Columbia

Dr. Andrea Califano leads a precision oncology clinical trial of the OncoTreat platform, which looks at proteins to determine treatment.

Noelle LoConte, MD
Research
January 13, 2021 • 5 Min

Finding More Targets for Pancreatic Cancer Treatment

Dr. Noelle LoConte discusses a clinical trial for cancer patients, including pancreatic cancer patients, that have an NRG1 gene fusion.

Researchers Andrew Aguirre and David Ting
Research
October 26, 2020 • 6 Min

Tumor Subtypes Potentially Provide Clues About Prognosis and Treatment

Drs. Andrew Aguirre and David Ting are teasing out the differences between pancreatic cancer subtypes, to get treatments that work better.

Dr. Jennifer Knox
Research
July 15, 2020 • 6 Min

Canadian Study NeoPancONE Focuses on Biomarker Validation

Dr. Jennifer Knox is leading the NeoPancONE trial for a biomarker that indicates which patients will respond better to certain chemotherapy before surgery.

PanCAN CSO Lynn Matrisian
Research
April 3, 2020 • 5 Min

Tumor Biology Matters

Dr. Lynn Matrisian of PanCAN, explains that molecular profiling of a pancreatic cancer patient’s tumor can show which treatment will work best.

Dr. Andrea Califano
Research
January 31, 2020 • 7 Min

Taking a Systems Biology Approach to Find a New Pancreatic Cancer Target

Dr. Andrea Califano is using systems biology and cell regulators to find new targets in the search for ways to stop pancreatic cancer cells.

Dr. David Chang
Research
July 8, 2019 • 5 Min

Pancreatic Cancer Patients in the UK Benefit From Unique Precision Medicine Project

Dr. David Chang explains the Precision Panc initiative, a program through the UK’s NHS that helps pancreatic cancer patients find treatments.

Kentaro Sudo lab
Research
May 15, 2019 • 5 Min

Representing Genetic and Clinical Diversity in Pancreatic Cancer

Dr. Kentaro Sudo explores the possible causes for different responses to drugs among ethnic groups, pointing to the need for clinical diversity in trials.

Dr. Vinod Balachandran
Research
March 13, 2019 • 5 Min

Pancreatic Cancer Exceptional Responders and the Immune System Link

Dr. Vinod Balachandran looks at the immune system of exceptional responders–patients who respond extremely well to chemotherapy–for treatment clues.

  • 1
  • 2